About this trial
The main goal of this retrospective observational study is to understand how stepping down antibiotic treatment (called antibiotic de-escalation) affects patients who receive it compared to those who don't after received a short-course (≤7 days) of parenteral antibiotics. The investigators will use past medical records from four public referral hospitals in Thailand from the year 2019 to 2024. The investigators will firstly evaluate which types of patients are more likely to receive antibiotic de-escalation. Then, the investigators will estimate the impact of antibiotic de-escalation, while taking those differences into account. This way, it will help us understand the impact of antibiotic de-escalation in real-world clinical practice. The investigators also aim to assess how accurate automated outbreak detection systems are at detecting outbreaks, evaluate patterns of antimicrobial use and antimicrobial-resistant infections, and develop new indicators for antimicrobial stewardship that are applicable for local and national actions in low and middle-income countries.
Eligibility criteria
Qualifiers
Admitted to four collaborating hospitals from 1 Jan 2019 to 31 Dec 2024
Received a parenteral antibiotic for at least four consecutive days
Were still hospitalized on day 8 after starting a parenteral antibiotic
Disqualifiers
Admitted as day admissions to four collaborating hospitals from 1 Jan 2019 to 31 Dec 2024
Had a clinical specimen collected within 2 calendar days of starting a parenteral antibiotic culture positive for an antimicrobial-resistant organism or Staphylococcus aureus
All age and gender
Admitted to four collaborating hospitals from 1 Jan 2019 to 31 Dec 2024
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of Oxford
Lead sponsor
Wellcome Trust
Collaborator